Partner Institutions

International Multiple Sclerosis Genetics Consortium (IMSGC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

• University of Eastern Piedmont "Amedeo Avogadro" (UNIPMN), Italy
• Broad Institute of MIT and Harvard, United States of America (USA)
• Cardiff University, United Kingdom (UK)
• Pierre and Marie Curie University (UPMC) - Paris 6, France
• Griffith University, Australia
• Harvard Medical School (HMS), United States of America (USA)
• Brigham and Women's Hospital (BWH), United States of America (USA)
• Charité - University Medicine Berlin, Germany
• MIT Whitehead Institute for Biomedical Research, United States of America (USA)
• University Medical Center Mainz, JGU, Germany
• Catholic University of Leuven (KU Leuven), Belgium
• Karolinska University Hospital, Sweden
• Keele University, United Kingdom (UK)
• National Institute for Health and Welfare (THL), Finland
• Peninsula College of Medicine and Dentistry (PCMD), United Kingdom (UK)
• Queen's University Belfast (QUB), United Kingdom (UK)
• San Raffaele Scientific Institute, Italy
• Technical University of Munich (TUM), Germany
• Wellcome Trust Sanger Institute, United Kingdom (UK)
• University of California, San Francisco (UCSF), United States of America (USA)
• UiO Ullevål Hospital, Norway
• University of California, Berkeley (UC Berkeley), United States of America (USA)
• University of Cambridge, United Kingdom (UK)
• University of Copenhagen (UCPH), Denmark
• The University of Melbourne (UniMelb), Australia
• Miller School of Medicine, UM, United States of America (USA)
• University of Montreal (UdeM), Canada
• The University of Newcastle (UON), Australia
• University of Oslo (UiO), Norway
• University of Otago, New Zealand
• The University of Sydney (USYD), Australia
• Vanderbilt University Medical Center (VUMC), United States of America (USA)
• Vall d'Hebron University Hospital (HUVH), ICS, Spain
• Rigshospitalet, Denmark